Suppression of experimental lung colonization of mouse colon adenocarcinoma 26 in vivo by an anti-idiotype monoclonal antibody recognizing a platelet surface molecule

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3040-3045

  Kato, Yukinari ^a   Fujita, Naoya ^a   Yano, Hideaki ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIGEN;

ADOLESCENT; ANIMAL CELL; ARTICLE; CANCER INHIBITION; COLON ADENOCARCINOMA; FEMALE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030745495     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Honn, K. V., Tang, D. G., and Crissman, J. D. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev., 11: 325-351, 1992
2. Bastida, E., and Ordinas, A. Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation. Haemostasis, 18: 29-36, 1988.
3. Mehta, P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood, 63: 55-63, 1984.
4. Gasic, G. J. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev., 3: 99-114, 1984.
5. Honn, K. V., Onoda, J. M., Diglio, C. A., Carufel, M. M., Taylor, J. D., and Sloane, B. F. Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine. Clin. Exp. Metastasis. 2: 61-72, 1984.
6. Tsuruo, T., Iida, H., Makishima, F., Yamori, T., Kawabata, H., Tsukagoshi, S., and Sakurai, Y. Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil. Cancer Chemother. Pharmacol., 14: 30-33, 1985.
7. Honn, K. V., Onoda, J. M., Pampalona, K., Battaglia, M., Neagos, G., Taylor, J. D., Diglio, C. A., and Sloane, B. F. Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. Biochem. Pharmacol., 34: 235-241, 1985.
8. Tsuruo, T., Yamori, T., Naganuma, K., Tsukagoshi, S., and Sakurai, Y. Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res., 43: 5437-5442, 1983.
9. Tsuruo, T., Kawabata, H., Iida, H., and Yamori, T. Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastasis, 4: 25-33, 1986.
10. Sugimoto, Y., Oh-hara, T., Watanabe, M., Saito, H., Yamori, T., and Tsuruo, T. Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res., 47: 4396-4401, 1987.
11. r 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res., 48: 6411-6416, 1988.
12. Sugimoto, Y., Watanabe, M., Oh-hara, T., Sato, S., Isoc, T., and Tsuruo, T. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res., 51: 921-925, 1991.
13. Toyoshima, M., Nakajima, M., Yamori, T., and Tsuruo, T. Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res., 55: 767-773, 1995.
14. Fujita, N., Kataoka, S., Naito, M., Heike, Y., Boku, N., Nakajima, M., and Tsuruo, T. Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules. Cancer Res., 53: 5022-5027, 1993.
15. Pearlstein, E., Salk, P. L., Yogeeswaran, G., and Karpatkin, S. Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc. Natl. Acad. Sci. USA, 77: 4336-4339, 1980.
16. Longenecker, G. L., Beyers, B. J., Bowen, R. J., and King, T. Human rhabdosarcoma cell-induced aggregation of blood platelets. Cancer Res., 49: 16-19, 1989.
17. Grossi, I. M., Fitzgerald, L. A., Umbarger, L. A., Nelson, K. K., Diglio, C. A., Taylor, J. D., and Honn, K. V. Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res., 49: 1029-1037, 1989.
18. Falanga, A., and Gordon, S. G. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry, 24: 5558-5567, 1985.
19. Cavanaugh, P. G., Sloane, B. F., Bajkowski, A. S., Taylor, J. D., and Honn, K. V. Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulam activity. Thromb. Res., 37: 309-326, 1985.
20. Chelladurai, M., Honn, K. V., and Walz, D. A. HLA-DR is a procoagulant. Biochem. Biophys. Res. Commun., 178: 467-473, 1991.
21. Dvorak, H. F., Van DeWater, L., Bitzer, A. M., Dvorak, A. M., Anderson, D., Harvey, V. S., Bach, R., Davis, G. L., DeWolf, W., and Carvalho, C. A. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res., 43: 4434-4441, 1983.
22. Bastida, E., Ordinas, A., Escolar, G., and Jamieson, G. A. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood, 64: 177-184, 1984.
23. Cavanaugh, P. G., Sloane, B. F., Bajkowski, A. S., Gasic, G. J., Gasic, T. B., and Honn, K. V. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin. Exp. Metastasis, 1: 297-307, 1983.
24. Phillips, D. R., Charo, I. F., and Scarborough, R. M. GPIIb-IIIa: the responsive integrin. Cell, 65: 359-362, 1991.
25. Boukerche, H., Berthier-Vergnes, O., Tabone, E., Dore, J. F., Leung, L. L., and McGregor, J. L. Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood, 74: 658-663, 1989.
26. Ligen, K. E., Mahalingam, M., Klein, P. A., and Kao, K. J. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide. J. Natl. Cancer Inst. (Bethesda), 80: 1461-1466, 1988.
27. Karpatkin, S., Pearlstein, E., Ambrogio, C., and Coller, B. S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J. Clin. Invest., 81: 1012-1019, 1988.
28. Clezardin, P., Drouin, J., Morel-Kopp, M., Hanss, M., Kehrel, B., Serre, C., Kaplan, C., and Delmas, P. D. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa and of platelet α-granule proteins in platelet aggregation induced by human osteosareoma cells. Cancer Res., 53: 4695-4700, 1993.
29. Weller, A., Isenmann, S., and Vestweber, D. Cloning of the mouse endothelial selectins. J. Biol. Chem., 267: 15176-15183, 1992.
30. Larsen, F., Celi, A., Gilbert, G. E., Furie, B. C., Erban, J. K., Bonfanti, R., Wagner, D. D., and Furie, B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell, 59: 305-312, 1989.
31. Aruffo, A., Dietsch, M. T., Wan, H., Hellström, K. E., and Hellström, I. Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl. Acad. Sci. USA, 89: 2292-2296, 1992.
32. 3, (platelet GPIIb-IIIa). Cell, 65: 409-416, 1991.
33. McEver, R. P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J. Cell Biochem., 45: 156-161, 1991.
34. r 41,000 glycoprotein associated with thrombin-independem platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res., 50: 6657-6662, 1990.
35. Nisonoff, A. Idiotypes: concepts and applications. J. Immunol., 147: 2429-2438, 1991.
36. Gong, K., Wen, D. Y., Ouyang, T., Rao, A. T., and Herzberg, M. C. Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies. Infect. Immun., 63: 3628-3633, 1995.
37. Pearlstein, E., Ambrogio, C., and Karpatkin, S. Effect of antiplatelet antibody on the development of pulmonary metastasis following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res., 44: 3884-3887, 1984.